色黑色素瘤 - 生物化学和分子诱导途径
Piotr Misiąg1,2, Klaudia Molik1,2, Monika Kisielewska1,2
1Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland.
International journal of molecular sciences
|November 9, 2024
概括
黑色素瘤是一种罕见而具有攻击性的皮肤癌亚型,具有诊断挑战. 了解其分子通路并探索包括免疫疗法在内的向疗法,可以改善临床管理和个性化医疗方法.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 黑色素瘤 (AM) 是一种罕见的黑色素瘤亚型,其特征是低颜色或完全缺乏黑色素.
- 与典型黑色素瘤相比,AM的复发率增加,攻击性增加,预后较差.
- 黑色素产生失调,细胞循环控制和细胞亡途径是AM的标志.
研究的目的:
- 总结和讨论AM的生化和分子诱导途径.
- 探索个性化医疗方法和AM的临床管理策略.
- 确定这种罕见的黑色素瘤亚型的未来研究方向.
主要方法:
- 文献综述和对AM现有研究的综合.
- 对参与AM病变发生的分子途径的分析.
- 评估当前和新兴的治疗策略,包括向疗法和免疫疗法.
主要成果:
- 亚米经常被误诊,突出了需要特定生物标志物的需要.
- BRAF,NRAS和c-KIT是关键的治疗点,尽管它们在AM中的作用是可变的.
- 组合疗法,如BRAF/MEK抑制剂和双免疫检查点抑制剂 (CTLA-4/PD-1),显示出有希望的结果.
结论:
- 向疗法和免疫疗法组合为AM提供了更好的结果.
- 对特定的AM生物标志物的进一步研究对于准确的诊断和治疗至关重要.
- 新兴的策略,如便微生物群移植和免疫调节疫苗,需要研究克服治疗耐药性的方法.
相关概念视频
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Skin Cancer
3.8K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.8K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


